National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

From the 1/14/2022 release of VAERS data:

Found 31,770 cases where Vaccine is COVID19 and Symptom is Cerebral venous sinus thrombosis or Cerebral venous thrombosis or Coagulopathy or Deep vein thrombosis or Disseminated intravascular coagulation or Embolism or Idiopathic thrombocytopenic purpura or Immune thrombocytopenia or Immune thrombocytopenic purpura or Ischaemic stroke or Myocardial infarction or Petechiae or Pulmonary embolism or Purpura or Thrombocytopenia or Thrombosis or Vasculitis

Government Disclaimer on use of this data



Case Details

This is page 23 out of 3,177

Result pages: prev   14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32   next


VAERS ID: 981787 (history)  
Form: Version 2.0  
Age: 61.0  
Sex: Male  
Location: Wisconsin  
Vaccinated:2021-01-19
Onset:2021-01-28
   Days after vaccination:9
Submitted: 0000-00-00
Entered: 2021-01-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / IM

Administered by: Private       Purchased by: ?
Symptoms: Chest pain, Computerised tomogram thorax abnormal, Fibrin D dimer increased, Hypopnoea, Lung opacity, Pleural effusion, Pulmonary embolism, SARS-CoV-2 test negative
SMQs:, Haemorrhage laboratory terms (broad), Interstitial lung disease (narrow), Systemic lupus erythematosus (broad), Embolic and thrombotic events, venous (narrow), Acute central respiratory depression (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Cardiomyopathy (broad), Eosinophilic pneumonia (broad), Respiratory failure (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 1 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Simvastatin, lisinopril
Current Illness: None
Preexisting Conditions: Hypertension, hyperlipidemia
Allergies: none
Diagnostic Lab Data: Elevated d-dimer. Negative rapid COVID test. CT scan showing Impression: Left upper and lower lobe subsegmental pulmonary emboli. Normal RV/LV ratio with flattening of the interventricular septum may indicate mild right heart strain. Groundglass opacity in the left lower lobe and lingula may be secondary to atelectasis. Pulmonary ischemia/infarction could also be considered. Small left pleural effusion.
CDC Split Type:

Write-up: pulmonary embolism that presented with chest pain and inability to take a deep breath, admitted and started on Heparin drip. Patient transitioned to Apixiban.


VAERS ID: 981912 (history)  
Form: Version 2.0  
Age: 67.0  
Sex: Female  
Location: California  
Vaccinated:2021-01-23
Onset:2021-01-23
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-01-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA UNKNOWN / 2 UN / IM

Administered by: Unknown       Purchased by: ?
Symptoms: Angiogram pulmonary abnormal, Cardiac arrest, Chest pain, Cold sweat, Death, Endotracheal intubation, Hypotension, Laboratory test, Pallor, Pulmonary embolism
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Angioedema (broad), Neuroleptic malignant syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Embolic and thrombotic events, venous (narrow), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Hypotonic-hyporesponsive episode (broad), Respiratory failure (broad), Hypoglycaemia (broad), Dehydration (broad), Hypokalaemia (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-27
   Days after onset: 4
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: albuterol, fluticasone nasal spray, hydrochlorothiazide, losartan
Current Illness:
Preexisting Conditions: hypertension
Allergies: none
Diagnostic Lab Data: 1/27 in the ED patient underwent a CTA chest to reveal PE, basic labs, alteplase 100 mg, amiodarone 150 mg followed by infusion, was intubated with rocuronium, and placed on a norepinephrine drip.
CDC Split Type:

Write-up: Patient presented to the Emergency Department complaining of chest pain, pale, cool diaphoretic, and hypotensive. The patient was discovered to have a large saddle pulmonary embolism, went into cardiac arrest and expired. Of note, the patient received her second Moderna COVID vaccine on 1/23, which would place her first one approximately 12/25 if she received them at the appropriate interval. This information is from the patient''s daughter and the ED record, the information is not available in CAIR. Per the daughter, the patient started feeling ill on 1/21, improved on 1/25, and then acutely worsened on 1/27, resulting in the ED visit.


VAERS ID: 981928 (history)  
Form: Version 2.0  
Age: 51.0  
Sex: Female  
Location: Puerto Rico  
Vaccinated:2021-01-08
Onset:2021-01-09
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-01-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / 1 UN / IM

Administered by: Other       Purchased by: ?
Symptoms: Activated partial thromboplastin time prolonged, Acute kidney injury, Alanine aminotransferase increased, Albumin globulin ratio decreased, Amylase normal, Anion gap increased, Aspartate aminotransferase increased, Basophil count increased, Basophil percentage, Blood albumin normal, Blood alkaline phosphatase increased, Blood bilirubin increased, Blood calcium decreased, Blood chloride normal, Blood cholesterol normal, Blood creatine increased, Blood creatinine increased, Blood glucose increased, Blood lactate dehydrogenase increased, Blood osmolarity increased, Blood potassium decreased, Blood smear test abnormal, Blood sodium normal, Blood urea increased, Carbon dioxide decreased, Disseminated intravascular coagulation, Eosinophil count decreased, Eosinophil percentage decreased, Gamma-glutamyltransferase increased, Globulin, Glomerular filtration rate decreased, Haematocrit decreased, Haemoglobin decreased, Hypoglycaemia, Immature granulocyte count increased, International normalised ratio increased, Lipase normal, Lymphocyte count decreased, Lymphocyte percentage decreased, Mean cell haemoglobin increased, Mean cell volume increased, Mean platelet volume normal, Mechanical ventilation, Monocyte count normal, Monocyte percentage decreased, Neutrophil count increased, Neutrophil percentage increased, Pancreatitis acute, Platelet count decreased, Pneumonia, Protein total decreased, Prothrombin time prolonged, Red blood cell count decreased, Red blood cell nucleated morphology, Red cell distribution width increased, Respiratory failure, Sepsis, White blood cell count increased
SMQs:, Rhabdomyolysis/myopathy (broad), Acute renal failure (narrow), Liver related investigations, signs and symptoms (narrow), Liver-related coagulation and bleeding disturbances (narrow), Anaphylactic reaction (broad), Acute pancreatitis (narrow), Haematopoietic erythropenia (narrow), Haematopoietic leukopenia (narrow), Haematopoietic thrombocytopenia (narrow), Lactic acidosis (broad), Haemorrhage terms (excl laboratory terms) (narrow), Haemorrhage laboratory terms (broad), Hyperglycaemia/new onset diabetes mellitus (narrow), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Retroperitoneal fibrosis (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (broad), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (broad), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Acute central respiratory depression (narrow), Biliary system related investigations, signs and symptoms (narrow), Guillain-Barre syndrome (broad), Eosinophilic pneumonia (broad), Chronic kidney disease (broad), Hypersensitivity (broad), Tumour lysis syndrome (narrow), Respiratory failure (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (narrow), Infective pneumonia (narrow), Dehydration (broad), Hypokalaemia (narrow), Sepsis (narrow), Opportunistic infections (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Benadryl 50mg PO HS, Duloxetine 30mg POD, Folic Acid 1mg POD, Gabapentin 300mg POD, Gemfibrozil 600mg POD, methotrexate 2.5mg PO weekly, Prednisone 5mg POD, Propranolol 80mg POD, Sulfasalazine 1gm POD
Current Illness:
Preexisting Conditions: rheumatoid arthritis, fibromyalgia, essential tremors, unspecified cardiac arrhythmia, anxiety
Allergies:
Diagnostic Lab Data: White Blood Count | 21.42 | H | 3.98-10.04 10^3/uL | | RECHECKED | | Red Blood Count | 3.29 | L | 3.93-5.22 10^6/uL | Hemoglobin | 11.00 | L | 11.2-15.7 g/dL | Hematocrit | 34.10 | | 34.1-44.9 % | Mean Corpuscular Volume | 103.6 | H | 79.0-94.8 fL | Mean Corpuscular Hemoglobin | 33.4 | H | 25.6-32.2 pg | Mean Corpuscular HGB Conc | 32.3 | | 32.2-36.5 g/dL | RDW Standard Deviation | 57.3 | H | 35.1-46.3 fL | RDW Coefficient of Variation | 14.9 | H | 11.6-14.4 % | Platelet Count | 52 | L | 163-369 10^3/uL | | RECHECKED | RESULTS CALLED TO RN AT 0326 BY MT | | PLATELETS ESTIMATED BY SMEAR | 2-10 PLTS/FIELD Mean Platelet Volume | 12.1 | | 9.4-12.4 fL | Neutrophils Percent Auto | 93.2 | H | 34.0-71.1 | Lymphocytes Percent Auto | 4.1 | L | 19.3-53.1 | Monocytes Percent Auto | 1.5 | L | 4.7-12.5 % | Eosinophils Percent Auto | 0.0 | L | 0.7-7.0 % | Basophils Percent Auto | 0.5 | | 0.1-1.2 % | Immature Granulocyte | 0.7 | H | 0.0-0.4 % | Neutrophils Absolute Auto | 19.96 | H | 1.56-6.13 10^3/uL | Lymphocytes Absolute Auto | 0.88 | L | 1.18-3.74 10^3/uL | Monocytes Absolute Auto | 0.32 | | 0.24-0.82 10^3/uL | Eosinophils Absolute Auto | 0.01 | L | 0.04-0.54 10^3/uL | Basophils Absolute Auto | 0.11 | H | 0.01-0.08 10^3/uL | Immature Granulocyte Absolute | 0.14 | H | 0.00-0.03 10^3/uL | Neutrophils Percent Manual | 68 | | 44-76 % | Band Neutrophils Percent | 16 | H | 2-6 % | Lymphocytes Percent Manual | 8 | L | 15-43 % | Monocytes Percent Manual | 8 | | 2-12 | Nucleated Red Blood Cells | 0.2 | | 0.0-1.0 % | Nucleated RBC Absolute | 0.04 | | 0.0-0.10 10^3/uL | Dohle Bodies | 1+ | | | PT/PTT COMBO Prothrombin Time | 16.90 | H | 9.5-12.0 sec | INR | 1.64 | H | 0.86-1.12 | Partial Thromboplastin Time | 42.50 | H | 24.0-33.0 sec | Sodium | 136 | | 136-145 mmol/L | Potassium | 3.20 | L | 3.50-5.10 mmol/L | Chloride | 100 | | 98-107 mmol/L | Carbon Dioxide | 13.00 | L | 21.00-32.00 mmol/L | Anion Gap | 23.00 | H | 10-20 | Blood Urea Nitrogen | 66.00 | H | 7.00-18.00 mg/dL | Creatinine | 4.53 | H | 0.6-1.30 mg/dL | Estimated Glomerular Filt Rate | 10.2 | | | | Reference Values: Greater than 60.0 mL/min/1.73 sqm. | Please multiply de GFR result by 1.210 in case of patients | who are African American. The IDMS-Traceable MDRD Study | Equation is applied to patients who are 18 year or older. | The MDRD Study equation has not been tested in children, the | elderly (over 70 years of age), pregnant women, patients | with serious comorbid conditions, or person with extremes of | body size, muscle mass or nutritional status. BUN Creatinine Ratio | 14.6 | | 12.0-20.0 mg/dL | Pharmacy Creatinine | 16.389 | | | Glucose | 221 | H | 74-106 mg/dL | Osmolality Calculated| 298.10 | H | 275.00-295.00 mmol/L | Calcium | 8.1 | L | 8.5-10.1 mg/dL | Total Bilirubin | 1.10 | H | 0.2-1.0 mg/dL | Direct Bilirubin | 0.80 | H | 0.0-0.3 mg/dL | Indirect Bilirubin | 0.30 | | 0.20-1.20 mg/dL | Gamma Glutamyl Transpeptidase | 86 | H | 5-55 U/L | Aspartate Amino Transferase | 121 | H | 15-37 U/L | Alanine Aminotransferase | 43 | | 12-78 U/L | Lactate Dehydrogenase| 672 | H | 84-246 U/L | Total Protein | 6.2 | L | 6.4-8.2 g/dL | Albumin | 3.6 | | 3.4-5.0 g/dL | Globulin | 2.6 | | 2.3-3.5 g/dL | Albumin Globulin Ratio | 1.38 | L | 1.50-2.2 g/dL | Cholesterol | 96 | | 0-240 mg/dL | | Reference Ranges: | | 2-17 years | Desirable: <170 mg/dL | Borderline High: 170-199 mg/dL | High: $g=200 mg/dL | | 18 years or Older | Desirable: <200 mg/dL | Bordeline High: 200-239 mg/dL | High: $g=240 mg/dL Alkaline Phosphatase | 241 | H | 42-117 U/L | Amylase | 74.00 | | 25.00-115.00 U/L | Lipase | 32 | | 12-53 U/L | | New reference range for Atellica Method.
CDC Split Type:

Write-up: Sepsis, Acute Pancreatitis, Respiratory Failure on Mechanical Ventilation, Disseminated Intravascular Coagulation, Pneumonia, Acute Kidney Injury. Refractory Hypoglycemia


VAERS ID: 982333 (history)  
Form: Version 2.0  
Age: 41.0  
Sex: Female  
Location: Pennsylvania  
Vaccinated:2021-01-25
Onset:2021-01-27
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-01-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 - / -

Administered by: Work       Purchased by: ?
Symptoms: Neutropenia, Neutrophil count decreased, Platelet count decreased, Thrombocytopenia, White blood cell count decreased
SMQs:, Agranulocytosis (broad), Haematopoietic leukopenia (narrow), Haematopoietic thrombocytopenia (narrow), Systemic lupus erythematosus (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Adderall 30 mg BID
Current Illness: none
Preexisting Conditions: h/o ITP, ADHD, anxiety, eosinophilic esophagitis, reflux esophagitis, Poland syndrome, seasonal allergies
Allergies: Gluten
Diagnostic Lab Data: 9/7/19: WBC 3.5, ANC 1.6, plats 166 1/4/21: COVID vaccine #1 1/14/21: WBC 4.2, ANC 2.1, plats 191 1/25/21: COVID vaccine #2 1/27/21: WBC 2.2, ANC 1.0, plats 130
CDC Split Type:

Write-up: neutropenia & thrombocytopenia


VAERS ID: 982388 (history)  
Form: Version 2.0  
Age: 45.0  
Sex: Male  
Location: Michigan  
Vaccinated:2021-01-12
Onset:2021-01-13
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-01-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL3248 / 2 LA / IM
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL00140 / 1 LA / IM

Administered by: Public       Purchased by: ?
Symptoms: Blood test, Computerised tomogram abnormal, Deep vein thrombosis, Pain in extremity, Pulmonary embolism, Ultrasound chest
SMQs:, Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad), Tendinopathies and ligament disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: Amlodipine, Fenofibrate, omeprazole, vitamin D, fish oil.
Current Illness: None
Preexisting Conditions: Hypertension, high triglycerides, GERD
Allergies: Emycin
Diagnostic Lab Data: I had blood tests, an ultrasound and a CT of my chest revealing a pulmonary embolism. My ER visit was on 01/14/21 *I have had a previous HX of DVT 5 years earlier from an injury. After speaking with my DR, they suggested that it would be a good idea to document this. Thank you.
CDC Split Type:

Write-up: The next morning I started to have some pain in my right calf which worsened throughout the day. The following day I went to the ER with a DVT. I was given Xarelto for treatment.


VAERS ID: 982689 (history)  
Form: Version 2.0  
Age: 52.0  
Sex: Female  
Location: California  
Vaccinated:2021-01-17
Onset:2021-01-27
   Days after vaccination:10
Submitted: 0000-00-00
Entered: 2021-01-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Angioedema, Injection site rash, Purpura
SMQs:, Anaphylactic reaction (broad), Angioedema (narrow), Haemorrhage terms (excl laboratory terms) (narrow), Oropharyngeal allergic conditions (narrow), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations: shingles vaccine
Other Medications: Red Yeast Rice extract, Co Q 10 Galrlic extarct Ziotin eye drops/ Zembreza eye drops
Current Illness: No
Preexisting Conditions: Elevated Cholesterol Glycoma
Allergies: Sulfa antibiotics Seasonal allergies
Diagnostic Lab Data: none
CDC Split Type:

Write-up: inital delayed reaction to injection site - puritic rash - 6 cm x 5 cm after day 11 patient developed upper and lower lip angioedema


VAERS ID: 983350 (history)  
Form: Version 2.0  
Age: 57.0  
Sex: Female  
Location: North Dakota  
Vaccinated:2021-01-07
Onset:2021-01-11
   Days after vaccination:4
Submitted: 0000-00-00
Entered: 2021-01-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL1284 / 1 LA / IM

Administered by: Work       Purchased by: ?
Symptoms: Thrombosis
SMQs:, Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies: penicillin
Diagnostic Lab Data:
CDC Split Type:

Write-up: Patient experienced a blood clot on January 11th. She is unsure if it is related to the vaccine or not.


VAERS ID: 984447 (history)  
Form: Version 2.0  
Age: 47.0  
Sex: Male  
Location: Mississippi  
Vaccinated:2021-01-15
Onset:2021-01-15
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-01-29
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL3247 / 1 LA / OT

Administered by: Military       Purchased by: ?
Symptoms: Hypoaesthesia oral, Lip swelling, Petechiae
SMQs:, Anaphylactic reaction (broad), Angioedema (narrow), Haemorrhage terms (excl laboratory terms) (narrow), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Guillain-Barre syndrome (broad), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None
Allergies:
Diagnostic Lab Data:
CDC Split Type: USPFIZER INC2021034788

Write-up: Transient numbness inside mouth buccal mucosa for about 3-5 minutes; Slight swelling upper left lip; 2cm petechia on border of left upper lip stopping at the midline; This is a spontaneous report from a contactable Other HCP (patient). A 47-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3247), Intramuscular at left arm on 15Jan2021 11:00 at SINGLE DOSE for covid-19 vaccination. Medical history was reported as none. The patient''s concomitant medications were not reported. On 15Jan2021 11:15, the patient experienced transient numbness inside mouth buccal mucosa for about 3-5 minutes, slight swelling upper left lip, 2cm petechia on border of left upper lip. Stopping at the midline. No treatment received for the events. No covid-prior-vaccination, no covid-tested-post-vaccination, no known allergies. The outcome of the events was recovering.


VAERS ID: 984515 (history)  
Form: Version 2.0  
Age: 45.0  
Sex: Female  
Location: D.C.  
Vaccinated:2021-01-14
Onset:2021-01-15
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-01-29
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL1284 / 1 LA / OT

Administered by: Private       Purchased by: ?
Symptoms: Blister, Burning sensation, Limb injury, Petechiae, SARS-CoV-2 test, Skin discolouration
SMQs:, Severe cutaneous adverse reactions (broad), Peripheral neuropathy (broad), Haemorrhage terms (excl laboratory terms) (narrow), Accidents and injuries (narrow), Hypotonic-hyporesponsive episode (broad), Hypersensitivity (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: PLAQUENIL [HYDROXYCHLOROQUINE SULFATE]; LEFLUNOMIDE; RESTASIS; PILOCARPINE; VITAMIN D [COLECALCIFEROL]; OMEGA 3 [FISH OIL]
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Abdominal hysterectomy; Bilateral salpingo-oophorectomy; Ovarian stromal cancer; Raynauds; Sjogren''s; Sulfonamide allergy
Allergies:
Diagnostic Lab Data: Test Date: 20210115; Test Name: Covid PCR Test (Nasal Swab); Test Result: Negative
CDC Split Type: USPFIZER INC2021042364

Write-up: petechiae with discoloration; petechiae with discoloration; L 2nd MTP and R 3rd MTP burning sensation; foot blister; stubbed a toe; This is a spontaneous report from a contactable nurse (patient). A 45-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number=EL1284) at Left arm, intramuscular on 14Jan2021 16:45 at single dose for covid-19 immunisation. Medical history included Sjogren''s, Raynaud, s/p Total abdominal hysterectomy (TAH)/Bilateral salpingo-oophorectomy (BSO) sex cord sclerosing stromal tumor, and known allergies: Sulfa. Patient did not have Covid prior vaccination. Concomitant medication included hydroxychloroquine sulfate (PLAQUENIL), leflunomide, ciclosporin (RESTASIS), pilocarpine, colecalciferol (VITAMIN D), fish oil (OMEGA 3). Since the 14Jan2021 Pfizer COVID vaccine, the patient had left (L) 2nd Metatarsophalangeal (MTP) and right (R) 3rd MTP burning sensation on 15Jan2021 10:00 (like she had foot blister or stubbed a toe). Then, she had petechiae with discoloration on 16Jan2021 and 17Jan2021. No treatment was received for the events. The patient lab data included Covid PCR Test (Nasal Swab): negative on 15Jan2021. The outcome of events was recovering.


VAERS ID: 984567 (history)  
Form: Version 2.0  
Age: 52.0  
Sex: Female  
Location: South Carolina  
Vaccinated:2021-01-05
Onset:2021-01-01
Submitted: 0000-00-00
Entered: 2021-01-29
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EK9231 / UNK LA / OT

Administered by: Private       Purchased by: ?
Symptoms: Blood count, Coagulation time, Fatigue, Investigation, Metabolic function test, Petechiae, Weight
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: CRESTOR
Current Illness: High cholesterol
Preexisting Conditions: Medical History/Concurrent Conditions: Sulfonamide allergy
Allergies:
Diagnostic Lab Data: Test Name: blood count; Result Unstructured Data: Test Result:Unknown Results; Test Name: clotting factors; Result Unstructured Data: Test Result:Unknown Results; Test Name: lab work; Result Unstructured Data: Test Result:labs were ok; Test Name: cmp; Result Unstructured Data: Test Result:Unknown Results; Test Name: Weight; Result Unstructured Data: Test Result:140 to 145 lbs
CDC Split Type: USPFIZER INC2021046423

Write-up: Petechia; felt fatigued; This is a spontaneous report from a contactable physician. A 52-years-old female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231), intramuscular on deltoid left from 05Jan2021 to 05Jan2021 at SINGLE DOSE for covid-19 immunisation. Medical history included ongoing blood cholesterol increased/high cholesterol and allergy to sulfa drugs. Concomitant medication included ongoing rosuvastatin calcium (CRESTOR) for blood cholesterol increased. The reporter stated that about 5 days later she noticed petechiae on her hands (10Jan2021). The patient also felt fatigue on Jan2021. She went to see her primary care doctor. She had lab work, blood count, clotting factors, and CMP done and states her labs were ok and the other test had unknown results on an unspecified date. The patient''s weight ranges from 140-145 lbs. The petechiae has slowly faded. Outcome of the event petechia was recovering while outcome of the event fatigue was unknown.


Result pages: prev   14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32   next

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=23&SYMPTOMS[]=Cerebral_venous_sinus_thrombosis_%2810083037%29&SYMPTOMS[]=Cerebral_venous_thrombosis_%2810008138%29&SYMPTOMS[]=Coagulopathy_%2810009802%29&SYMPTOMS[]=Deep_vein_thrombosis_%2810051055%29&SYMPTOMS[]=Disseminated_intravascular_coagulation_%2810013442%29&SYMPTOMS[]=Embolism_%2810061169%29&SYMPTOMS[]=Idiopathic_thrombocytopenic_purpura_%2810021245%29&SYMPTOMS[]=Immune_thrombocytopenia_%2810083842%29&SYMPTOMS[]=Immune_thrombocytopenic_purpura_%2810074667%29&SYMPTOMS[]=Ischaemic_stroke_%2810061256%29&SYMPTOMS[]=Myocardial_infarction_%2810028596%29&SYMPTOMS[]=Petechiae_%2810034754%29&SYMPTOMS[]=Pulmonary_embolism_%2810037377%29&SYMPTOMS[]=Purpura_%2810037549%29&SYMPTOMS[]=Thrombocytopenia_%2810043554%29&SYMPTOMS[]=Thrombosis_%2810043607%29&SYMPTOMS[]=Vasculitis_%2810047115%29&VAX=COVID19


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166